ArticleHeliyon2022

Pralatrexate mediates effective killing of gemcitabine-resistant pancreatic cancer: role of mTOR/4E-BP1 signal pathway.

Wanwen Weng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.